Aug 31, 2021

Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's.  We talk about the recent FDA approval of aducanumab and its impact on research.

Hideki says, "As we've shown at...

Aug 31, 2021

Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's.  We talk about the recent FDA approval of aducanumab and its impact on research.

Hideki says, "As we've shown at...

Aug 18, 2021

Professor Florian Solzbacher is the Co-Founder and Chairman of Blackrock Neurotech and is focused on expanding the options, understanding, and marketing of brain computer interfaces and neuro devices.

I asked Florian about their new project underway with Northwestern University and DARPA called the NTRAIN Project....

Aug 18, 2021

Professor Florian Solzbacher is the Co-Founder and Chairman of Blackrock Neurotech and is focused on expanding the options, understanding, and marketing of brain computer interfaces and neuro devices.

I asked Florian about their new project underway with Northwestern University and DARPA called the NTRAIN Project....

Jul 13, 2021

Bill Hagstrom is the CEO and Founder of Octave Bioscience, looking at ways to dynamically assess patients with multiple sclerosis and other neurodegenerative diseases to manage their treatment plan better.

Bill says, "There's an enormous opportunity to take a personalized approach to managing these patients. MS and...